Abstract:Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that mediate the majority of excitatory neurotransmission in the vertebrate CNS. Classified as AMPA, kainate, delta and NMDA receptors, iGluRs are central drivers of synaptic plasticity widely considered as a major cellular substrate of learning and memory. Surprisingly however, five out of the eighteen vertebrate iGluR subunits do not bind glutamate but glycine, a neurotransmitter known to mediate inhibitory neurotransmission through its action on pentameric glycine receptors (GlyRs). This is the case of GluN1, GluN3A, GluN3B, GluD1 and GluD2 subunits, all also binding the D amino acid d-serine endogenously present in many brain regions. Glycine and d-serine action and affinities broadly differ between glycinergic iGluR subtypes. On 'conventional' GluN1/GluN2 NMDA receptors, glycine (or d-serine) acts in concert with glutamate as a mandatory co-agonist to set the level of receptor activity. It also regulates the receptor's trafficking and expression independently of glutamate. On 'unconventional' GluN1/GluN3 NMDARs, glycine acts as the sole agonist directly triggering opening of excitatory glycinergic channels recently shown to be physiologically relevant. On GluD receptors, d-serine on its own mediates non-ionotropic signaling involved in excitatory and inhibitory synaptogenesis, further reinforcing the concept of glutamate-insensitive iGluRs. Here we present an overview of our current knowledge on glycine and d-serine agonism in iGluRs emphasizing aspects related to molecular mechanisms, cellular function and pharmacological profile. The growing appreciation of the critical influence of glycine and d-serine on iGluR biology reshapes our understanding of iGluR signaling diversity and complexity, with important implications in neuropharmacology.

The Startle Disease Mutation E103K Impairs Activation of Human Homomeric Α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge Across the Agonist Binding Site

Role of the Glycine Receptor β Subunit in Synaptic Localization and Pathogenicity in Severe Startle Disease

Agonist and Antagonist Binding in Human Glycine Receptors.

The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element

Interaction Of The Glycine Receptor Alpha 1 Binding Site With Partial Agonists

Exploring the Activation Process of the Glycine Receptor

Presynaptic Glycine Receptors As A Potential Therapeutic Target for Hyperekplexia Disease

The Kinetic Properties of the Human Glycine Receptor in Response to Different Agonists

A loss-of-function mutation of an inhibitory zinc- and proton-binding site reduces channel blocker potency in the glycine receptor

Towards Understanding the Interaction of Agonists with the Human Α1 Glycine Receptor

Characterization Of Two Mutations, M287l And Q266i, In The Alpha 1 Glycine Receptor Subunit That Modify Sensitivity To Alcohols

Aminomethanesulfonic acid illuminates the boundary between full and partial agonists of the pentameric glycine receptor

Glycine agonism in ionotropic glutamate receptors

Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors

Human Hyperekplexic Mutations in Glycine Receptors Disinhibit the Brainstem by Hijacking GABAA Receptors.

Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists

Potassium Channel Gating in the Absence of the Highly Conserved Glycine of the Inner Transmembrane Helix

Modelling and Molecular Dynamics Predict the Structure and Interactions of the Glycine Receptor Intracellular Domain

Mutations M287l And Q266i In The Glycine Receptor Alpha 1 Subunit Change Sensitivity To Volatile Anesthetics In Oocytes And Neurons, But Not The Minimal Alveolar Concentration In Knockin Mice

Molecular Determinants of Glycine-Independent Desensitization of NR1/NR2A Receptors

Unmasking GluN1/GluN3A excitatory glycine NMDA receptors